Trial intelligence / Profile preview

COPIA Feasibility Trial: Propofol vs Inhalational Anaesthetics after Cardiac Surgery

2019-000171-16Phase 4Unknown

Sponsor
King's College Hospital
Start
Jul 2019
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of propofol, desflurane, isoflurane and sevoflurane in ischemia-reperfusion injury (IRI) and coronary arteriosclerosis (2 arms), sponsored by King's College Hospital. Primary endpoints: Feasibility of study protocol and Follow-up rate at 30 days. Status: unknown.

02

Drugs

propofoldesfluraneisofluranesevoflurane
03

Conditions

ischemia-reperfusion injury (IRI)coronary arteriosclerosis

Beyond the preview

Go deeper on 2019-000171-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-000171-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call